Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph+ALL)

Abstract 1503 (Objective) The treatment outcome of patients with Ph+ ALL has significantly improved since the advent of TKIs such as imatinib and dasatinib. However, the long-term survival of these patients is not necessarily high when bone marrow transplantation (BMT) is not performed. The present...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 118; no. 21; p. 1503
Main Authors Kyo, Taiichi, Okatani, Takeshi, Kyo, Kouhei, Imanaka, Ryouta, Itagaki, Mitsuhiro, Katayama, Yuuta, Iwato, Koji, Asaoku, Hideki
Format Journal Article
LanguageEnglish
Published Elsevier Inc 18.11.2011
Online AccessGet full text
ISSN0006-4971
1528-0020
DOI10.1182/blood.V118.21.1503.1503

Cover